IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice

Mucosal Immunology

Volumn 7, Issue 3, 2014, Pages 625-633

  Visperas, A ^a,b   Do, J S ^a   Bulek, K ^a   Li, X ^a   Min, B ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR ALPHA; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; ANTIGEN; INTERLEUKIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH17 CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DENDRITIC CELL; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COLITIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; INTERLEUKIN-27; MACROPHAGES; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN; TH17 CELLS;

EID: 84899495625     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.82     Document Type: Article

References (37)

1. Zhu, J., Yamane, H. & Paul, W.E. Differentiation of effector CD4 T cell populations (?). Annu Rev Immunol 28, 445-489 (2010).
2. Kaser, A., Zeissig, S. & Blumberg, R.S. Inflammatory bowel disease. Annu Rev Immunol 28, 573-621 (2010).
3. Kebir, H. et al. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol 66, 390-402 (2009).
4. Do, J.S., Visperas, A., Dong, C., Baldwin, W.M. III & Min, B. Cutting edge: generation of colitogenic Th17 CD4 T cells is enhanced by IL-17+ gammadelta T cells. J Immunol 186, 4546-4550 (2011).
5. Pflanz, S. et al. WSX-1 and glycoprotein 130 constitute a signaltransducing receptor for IL-27. J Immunol 172, 2225-2231 (2004).
6. Hall, A.O., Silver, J.S. & Hunter, C.A. The immunobiology of IL-27. Adv Immunol 115, 1-44 (2012).
7. Hibbert, L., Pflanz, S., De Waal Malefyt, R. & Kastelein, R.A. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23, 513-522 (2003).
8. Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7, 929-936 (2006).
9. Diveu, C. et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182, 5748-5756 (2009).
10. Hall, A.O. et al. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37, 511-523 (2012).
11. Cox, J.H., Kljavin, N.M., Ramamoorthi, N., Diehl, L., Batten, M. & Ghilardi, N. IL-27 promotes T cell-dependent colitis through multiple mechanisms. J Exp Med 208, 115-123 (2011).
12. Schmidt, C. et al. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11, 16-23 (2005).
13. Imielinski, M. et al. Common variants at five new loci associated with earlyonset inflammatory bowel disease. Nat Genet 41, 1335-1340 (2009).
14. Honda, K. et al. T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis. Inflamm Bowel Dis 11, 1044-1052 (2005).
15. Troy,A.E. et al. IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. J Immunol 183, 2037-2044 (2009).
16. Feng, X.M. et al. Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27. Biochem Biophys Res Commun 367, 553-559 (2008).
17. Guzzo, C., Ayer, A., Basta, S., Banfield, B.W. & Gee, K. IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes. J Immunol 188, 864-873 (2012).
18. Holscher, C. et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174, 3534-3544 (2005).
19. Leppkes, M. et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136, 257-267 (2009).
20. Wedebye Schmidt, E.G. et al. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis. Inflamm Bowel Dis 19, 1567-1576 (2013).
21. Stumhofer, J.S. et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol 11, 1119-1126 (2010).
22. Hirahara, K. et al. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36, 1017-1030 (2012).
23. Oberg, H.H., Wesch, D., Grussel, S., Rose-John, S. & Kabelitz, D. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25-and CD25high regulatory T cells. Int Immunol 18, 555-563 (2006).
24. Ito, H. & Fathman, C.G. CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease. J Autoimmun 10, 455-459 (1997).
25. Simpson, S.J. et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 187, 1225-1234 (1998).
26. Li, J.P. et al. [IL-27 regulates the expression ofMac-1, fMLP-Rand IL-1beta in human neutrophils through p38 MAPK and PI3K signal pathways]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18, 391-395 (2010).
27. Beetz, A. et al. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int J Radiat Biol 76, 1443-1453 (2000).
28. Kim, G., Shinnakasu, R., Saris, C.J., Cheroutre, H. & Kronenberg, M. A novel role for IL-27 in mediating the survival of activated mouse CD4 T lymphocytes. J Immunol 2013)190, 1510-1518.
29. Mendel, I., Katz, A., Kozak, N., Ben-Nun, A. & Revel, M. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur J Immunol 28, 1727-1737 (1998).
30. Molle, C., Goldman, M. & Goriely, S. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J Immunol 184, 1784-1792 (2010).
31. Kole, A. et al. Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cellmediated colitis. J Immunol 191, 2771-2779 (2013).
32. Owaki, T. et al. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol 176, 2773-2780 (2006).
33. Zeitvogel, J. et al. Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages. J Biol Chem 287, 9923-9930 (2012).
34. Spence, S. et al. Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 38, 66-78s (2012).
35. Li, Y., de Haar, C., Peppelenbosch, M.P. & van der Woude, C.J. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer. Cytokine Growth Factor Rev 23, 127-138 (2012).
36. Brimnes, J., Reimann, J., Nissen, M. & Claesson, M. Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease. Eur J Immunol 31, 23-31 (2001).
37. O'Connor, W. Jr. et al. A protective function for interleukin 17A in T cellmediated intestinal inflammation. Nat Immunol 10, 603-609 (2009).